Vertex Pharmaceuticals Stock Market Value
| VRTX Stock | USD 465.02 3.78 0.82% |
| Symbol | Vertex |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vertex Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.047 | Earnings Share 14.21 | Revenue Per Share | Quarterly Revenue Growth 0.11 | Return On Assets |
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Vertex Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Vertex Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vertex Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vertex Pharmaceuticals.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Vertex Pharmaceuticals on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Vertex Pharmaceuticals or generate 0.0% return on investment in Vertex Pharmaceuticals over 90 days. Vertex Pharmaceuticals is related to or competes with McKesson, HCA Holdings, Medtronic PLC, Sanofi ADR, Regeneron Pharmaceuticals, GlaxoSmithKline PLC, and Bristol Myers. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for tr... More
Vertex Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vertex Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vertex Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.46 | |||
| Information Ratio | 0.0703 | |||
| Maximum Drawdown | 9.91 | |||
| Value At Risk | (2.49) | |||
| Potential Upside | 4.17 |
Vertex Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vertex Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vertex Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Vertex Pharmaceuticals historical prices to predict the future Vertex Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0986 | |||
| Jensen Alpha | 0.1333 | |||
| Total Risk Alpha | 0.0401 | |||
| Sortino Ratio | 0.088 | |||
| Treynor Ratio | 0.2141 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vertex Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vertex Pharmaceuticals February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0986 | |||
| Market Risk Adjusted Performance | 0.2241 | |||
| Mean Deviation | 1.33 | |||
| Semi Deviation | 1.31 | |||
| Downside Deviation | 1.46 | |||
| Coefficient Of Variation | 873.19 | |||
| Standard Deviation | 1.83 | |||
| Variance | 3.34 | |||
| Information Ratio | 0.0703 | |||
| Jensen Alpha | 0.1333 | |||
| Total Risk Alpha | 0.0401 | |||
| Sortino Ratio | 0.088 | |||
| Treynor Ratio | 0.2141 | |||
| Maximum Drawdown | 9.91 | |||
| Value At Risk | (2.49) | |||
| Potential Upside | 4.17 | |||
| Downside Variance | 2.13 | |||
| Semi Variance | 1.73 | |||
| Expected Short fall | (1.53) | |||
| Skewness | 1.01 | |||
| Kurtosis | 2.3 |
Vertex Pharmaceuticals Backtested Returns
At this stage we consider Vertex Stock to be very steady. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0638, which indicates the firm had a 0.0638 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Vertex Pharmaceuticals, which you can use to evaluate the volatility of the company. Please validate Vertex Pharmaceuticals' Coefficient Of Variation of 873.19, semi deviation of 1.31, and Risk Adjusted Performance of 0.0986 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%. Vertex Pharmaceuticals has a performance score of 5 on a scale of 0 to 100. The entity has a beta of 0.93, which indicates possible diversification benefits within a given portfolio. Vertex Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Vertex Pharmaceuticals is expected to follow. Vertex Pharmaceuticals right now has a risk of 1.85%. Please validate Vertex Pharmaceuticals value at risk, kurtosis, price action indicator, as well as the relationship between the semi variance and rate of daily change , to decide if Vertex Pharmaceuticals will be following its existing price patterns.
Auto-correlation | 0.10 |
Insignificant predictability
Vertex Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Vertex Pharmaceuticals time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vertex Pharmaceuticals price movement. The serial correlation of 0.1 indicates that less than 10.0% of current Vertex Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | 0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 133.94 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.